cbdMD Inc Total Liabilities
cbdMD Inc total liabilities. Based on the latest financial reports, cbdMD Inc (YCBD) has total liabilities worth $3.78 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check YCBD cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of cbdMD Inc (2015–2024)
Total liabilities of cbdMD Inc from 2015 to 2024. This chart illustrates how cbdMD Inc's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of cbdMD Inc to see how much of total assets are deployed in long-term investments.
cbdMD Inc Competitors by Total Liabilities
The table below lists competitors of cbdMD Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sidomulyo Selaras Tbk
JK:SDMU
|
Indonesia | Rp116.09 Billion |
|
Capitol Nusantara Indonesia
JK:CANI
|
Indonesia | Rp691.34 Billion |
|
ZINC of Ireland NL
AU:ZMI
|
Australia | AU$634.51K |
|
ChoA Pharmaceutical Co.Ltd
KQ:034940
|
Korea | ₩41.51 Billion |
|
Kaili Resources Ltd
AU:KLR
|
Australia | AU$5.39 Million |
|
Luminar Technologies
NASDAQ:LAZR
|
USA | $505.08 Million |
|
Syra Health Corp. Class A Common Stock
NASDAQ:SYRA
|
USA | $1.58 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down cbdMD Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see cbdMD Inc asset portfolio.
Liquidity & Leverage Metrics
cbdMD Inc Total Liabilities Ratios Explained
cbdMD Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how cbdMD Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for cbdMD Inc (2015–2024)
The table below shows the annual total liabilities of cbdMD Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-09-30 | $8.62 Million | +20.30% |
| 2023-09-30 | $7.16 Million | -23.52% |
| 2022-09-30 | $9.37 Million | -56.91% |
| 2021-09-30 | $21.74 Million | -31.33% |
| 2020-09-30 | $31.66 Million | -44.37% |
| 2019-09-30 | $56.91 Million | +5600.21% |
| 2018-09-30 | $998.46K | -48.01% |
| 2017-09-30 | $1.92 Million | +0.23% |
| 2016-09-30 | $1.92 Million | +251.31% |
| 2015-09-30 | $545.41K | -- |
About cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated p… Read more